Zomedica Corp.
ZOM was delisted on the 4th of March, 2025.
96 hedge funds and large institutions have $12.4M invested in Zomedica Corp. in 2024 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 13 closing their positions.
0% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 13
0% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 16
0% less capital invested
Capital invested by funds: $12.4M → $12.4M (-$21.3K)
3% less funds holding
Funds holding: 99 → 96 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$412K |
| 2 |
State Street
Boston,
Massachusetts
|
+$59.8K |
| 3 |
SWM
Spire Wealth Management
Mclean,
Virginia
|
+$32.9K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$32.2K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$27.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Atom Investors
Austin,
Texas
|
-$175K |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$139K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$76.8K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$44.9K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$35.3K |
ZOM Hedge Fund Activity: Q2 2024 in Review
96 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q2 2024, worth a combined $12.4M — down 0.17% from $12.4M a quarter earlier.
Fund positioning in ZOM was balanced in Q2 2024: 13 funds opened new positions, 13 closed out, 16 added to existing stakes and 16 trimmed.
The largest buyer was GSA Capital Partners, adding an estimated $412K. The largest seller was Atom Investors, exiting entirely with an estimated $175K sold.
- 96 institutional investors held Zomedica Corp. (ZOM) as of Q2 2024, down from 99 in Q1 2024.
- Funds reported $12.4M of Zomedica Corp. stock for Q2 2024, down 0.17% quarter-over-quarter.
- 13 funds opened new Zomedica Corp. positions in Q2 2024 and 13 closed out, a net change of 0 holders.
- The largest Zomedica Corp. buyer in Q2 2024 was GSA Capital Partners, an estimated $412K added.
- The largest Zomedica Corp. seller in Q2 2024 was Atom Investors, an estimated $175K sold.
Based on aggregated 13F filings for Q2 2024.